Valuation (2%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -66.82 | N/A |
PEG Ratio (TTM) | -2.08 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 38.96 | N/A |
P/FCF Ratio (TTM) | -143.13 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -56.65% | N/A |
ROE (TTM) | -58.27% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 49.41% | -565.00% | N/A |
Revenue | N/A | N/A | N/A |
Net Income | 47.74% | -749.34% | N/A |
Cash Flow | 47.67% | -1,036.70% | N/A |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 35.08 | N/A |
Quick Ratio (TTM) | 35.08 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | -414.00 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |